Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Commodore Capital LP reported a 9.90% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)
Filed Aug 14, 2026
Commodore Capital LP reported a 9.90% stake in Vistagen Therapeutics, Inc., 4,244,590 shares, as a passive investor. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 4,244,590
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 4,244,590 |
| Commodore Capital Master LP | 9.90% | 4,244,590 |
| Robert Egen Atkinson | 9.90% | 4,244,590 |
| Michael Kramarz | 9.90% | 4,244,590 |
Source
Related
- Vistagen Therapeutics, Inc.
- Commodore Capital LP
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026
- Form 4 · Singh Shawn · Jul 2, 2026